Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
15678 | 698 | 39.7 | 76% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
408 | 3 | CHIM BIOINORGAN//POLO SCI//CARBONIC ANHYDRASE | 29468 |
1363 | 2 | TIRAPAZAMINE//DT DIAPHORASE//BIOREDUCTIVE DRUGS | 8244 |
15678 | 1 | TIRAPAZAMINE//BIOREDUCTIVE DRUGS//SR 4233 | 698 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TIRAPAZAMINE | authKW | 2645049 | 13% | 68% | 89 |
2 | BIOREDUCTIVE DRUGS | authKW | 990826 | 7% | 46% | 49 |
3 | SR 4233 | authKW | 869753 | 4% | 76% | 26 |
4 | AQ4N | authKW | 789606 | 3% | 95% | 19 |
5 | HYPOXIA ACTIVATED PRODRUG | authKW | 752004 | 3% | 90% | 19 |
6 | PR 104 | authKW | 615171 | 2% | 94% | 15 |
7 | NLCQ 1 | authKW | 524947 | 2% | 100% | 12 |
8 | AUCKLAND CANC SOC | address | 506177 | 12% | 13% | 86 |
9 | HYPOXIC CYTOTOXIN | authKW | 468694 | 2% | 71% | 15 |
10 | TH 302 | authKW | 434877 | 2% | 76% | 13 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 5164 | 45% | 0% | 312 |
2 | Chemistry, Medicinal | 1515 | 14% | 0% | 100 |
3 | Radiology, Nuclear Medicine & Medical Imaging | 475 | 11% | 0% | 78 |
4 | Pharmacology & Pharmacy | 468 | 17% | 0% | 120 |
5 | Chemistry, Organic | 116 | 7% | 0% | 52 |
6 | Toxicology | 105 | 4% | 0% | 31 |
7 | Chemistry, Inorganic & Nuclear | 86 | 5% | 0% | 35 |
8 | Chemistry, Multidisciplinary | 78 | 10% | 0% | 69 |
9 | Crystallography | 41 | 3% | 0% | 19 |
10 | Biology | 35 | 3% | 0% | 19 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AUCKLAND CANC SOC | 506177 | 12% | 13% | 86 |
2 | EXPT ONCOL GRP | 88571 | 1% | 23% | 9 |
3 | DCTDFAIRVIEW | 87491 | 0% | 100% | 2 |
4 | AUCKLAND CANC SOCIETY | 49210 | 0% | 38% | 3 |
5 | ANN BARBARA KARRNANOS CANC | 43746 | 0% | 100% | 1 |
6 | AUSTRALYAN SYNCHROTRON PROGRAM | 43746 | 0% | 100% | 1 |
7 | BIOMED PROTE PLATFORM | 43746 | 0% | 100% | 1 |
8 | BROMATOL FOOD TECHNOL TOXICOL | 43746 | 0% | 100% | 1 |
9 | CANC UK CLLIN | 43746 | 0% | 100% | 1 |
10 | CHIRURG GINECOL | 43746 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTI-CANCER DRUG DESIGN | 10023 | 2% | 2% | 12 |
2 | ONCOLOGY RESEARCH | 7129 | 2% | 1% | 14 |
3 | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 4217 | 6% | 0% | 41 |
4 | BRITISH JOURNAL OF CANCER | 3677 | 6% | 0% | 39 |
5 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1698 | 2% | 0% | 17 |
6 | CHEMICAL RESEARCH IN TOXICOLOGY | 1627 | 2% | 0% | 14 |
7 | JOURNAL OF MEDICINAL CHEMISTRY | 1341 | 4% | 0% | 26 |
8 | BIOCHEMICAL PHARMACOLOGY | 1219 | 3% | 0% | 23 |
9 | RADIATION ONCOLOGY INVESTIGATIONS | 970 | 0% | 2% | 1 |
10 | CLINICAL CANCER RESEARCH | 928 | 3% | 0% | 18 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TIRAPAZAMINE | 2645049 | 13% | 68% | 89 | Search TIRAPAZAMINE | Search TIRAPAZAMINE |
2 | BIOREDUCTIVE DRUGS | 990826 | 7% | 46% | 49 | Search BIOREDUCTIVE+DRUGS | Search BIOREDUCTIVE+DRUGS |
3 | SR 4233 | 869753 | 4% | 76% | 26 | Search SR+4233 | Search SR+4233 |
4 | AQ4N | 789606 | 3% | 95% | 19 | Search AQ4N | Search AQ4N |
5 | HYPOXIA ACTIVATED PRODRUG | 752004 | 3% | 90% | 19 | Search HYPOXIA+ACTIVATED+PRODRUG | Search HYPOXIA+ACTIVATED+PRODRUG |
6 | PR 104 | 615171 | 2% | 94% | 15 | Search PR+104 | Search PR+104 |
7 | NLCQ 1 | 524947 | 2% | 100% | 12 | Search NLCQ+1 | Search NLCQ+1 |
8 | HYPOXIC CYTOTOXIN | 468694 | 2% | 71% | 15 | Search HYPOXIC+CYTOTOXIN | Search HYPOXIC+CYTOTOXIN |
9 | TH 302 | 434877 | 2% | 76% | 13 | Search TH+302 | Search TH+302 |
10 | BIOREDUCTIVE AGENTS | 341670 | 2% | 46% | 17 | Search BIOREDUCTIVE+AGENTS | Search BIOREDUCTIVE+AGENTS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PHILLIPS, RM , (2016) TARGETING THE HYPOXIC FRACTION OF TUMOURS USING HYPOXIA-ACTIVATED PRODRUGS.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 77. ISSUE 3. P. 441 -457 | 60 | 54% | 8 |
2 | DENNY, WA , WILSON, WR , (2000) TIRAPAZAMINE: A BIOREDUCTIVE ANTICANCER DRUG THAT EXPLOITS TUMOUR HYPOXIA.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 9. ISSUE 12. P. 2889 -2901 | 67 | 74% | 56 |
3 | HAY, MP , HICKS, KO , WANG, JL , (2014) HYPOXIA-DIRECTED DRUG STRATEGIES TO TARGET THE TUMOR MICROENVIRONMENT.TUMOR MICROENVIRONMENT AND CELLULAR STRESS: SIGNALING, METABOLISM, IMAGING, AND THERAPEUTIC TARGETS. VOL. 772. ISSUE . P. 111-145 | 94 | 37% | 6 |
4 | SHEN, XL , RAJAPAKSE, A , GALLAZZI, F , JUNNOTULA, V , FUCHS-KNOTTS, T , GLASER, R , GATES, KS , (2014) ISOTOPIC LABELING EXPERIMENTS THAT ELUCIDATE THE MECHANISM OF DNA STRAND CLEAVAGE BY THE HYPOXIA-SELECTIVE ANTITUMOR AGENT 1,2,4-BENZOTRIAZINE 1,4-DI-N-OXIDE.CHEMICAL RESEARCH IN TOXICOLOGY. VOL. 27. ISSUE 1. P. 111 -118 | 44 | 70% | 1 |
5 | GUISE, CP , MOWDAY, AM , ASHOORZADEH, A , YUAN, R , LIN, WH , WU, DH , SMAILL, JB , PATTERSON, AV , DING, K , (2014) BIOREDUCTIVE PRODRUGS AS CANCER THERAPEUTICS: TARGETING TUMOR HYPOXIA.CHINESE JOURNAL OF CANCER. VOL. 33. ISSUE 2. P. - | 41 | 59% | 26 |
6 | JOHNSON, KM , PARSONS, ZD , BARNES, CL , GATES, KS , (2014) TOWARD HYPOXIA-SELECTIVE DNA-ALKYLATING AGENTS BUILT BY GRAFTING NITROGEN MUSTARDS ONTO THE BIOREDUCTIVELY ACTIVATED, HYPOXIA-SELECTIVE DNA-OXIDIZING AGENT 3-AMINO-1,2,4-BENZOTRIAZINE 1,4-DIOXIDE (TIRAPAZAMINE).JOURNAL OF ORGANIC CHEMISTRY. VOL. 79. ISSUE 16. P. 7520 -7531 | 46 | 59% | 6 |
7 | MCKEOWN, SR , COWENT, RL , WILLIAMS, KJ , (2007) BIOREDUCTIVE DRUGS: FROM CONCEPT TO CLINIC.CLINICAL ONCOLOGY. VOL. 19. ISSUE 6. P. 427-442 | 64 | 41% | 96 |
8 | LEE, CI , HUANG, CM , HUANG, WH , LEE, AR , (2014) SYNTHESIS, PREFERENTIALLY HYPOXIC APOPTOSIS AND ANTI-ANGIOGENIC ACTIVITY OF 3-AMINO-1,2,4-BENZOTRIAZINE-1,4-DIOXIDE BEARING ALKYL LINKERS WITH A 3-AMINO-1,2,4-BENZOTRIAZINE-1-OXIDE MOIETY.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 14. ISSUE 10. P. 1428 -1446 | 32 | 82% | 0 |
9 | HAY, MP , HICKS, KO , PCHALEK, K , LEE, HH , BLASER, A , PRUIJN, FB , ANDERSON, RF , SHINDE, SS , WILSON, WR , DENNY, WA , (2008) TRICYCLIC [1,2,4]TRIAZINE 1,4-DIOXIDES AS HYPOXIA SELECTIVE CYTOTOXINS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 51. ISSUE 21. P. 6853 -6865 | 42 | 68% | 25 |
10 | CHEN, Y , HU, LQ , (2009) DESIGN OF ANTICANCER PRODRUGS FOR REDUCTIVE ACTIVATION.MEDICINAL RESEARCH REVIEWS. VOL. 29. ISSUE 1. P. 29 -64 | 65 | 33% | 154 |
Classes with closest relation at Level 1 |